N/A
N=529
The Impact on Linkage-to-care of an Alternative Hepatitis C Screening Method in PWID
Hepatitis C · Drug Users · Harm Reduction · HIV
Bottom Line
View on ClinicalTrials.gov: NCT02971488 ↗Enrolled (actual)
529
Serious AEs
0.0%
Results posted
Sep 2019
Primary outcome: Primary: Percentage of HCV Infected Paticipants Whom Result of the Test Was Delivered to — 101 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Screening for HCV in PWID and Linkage-To-Care (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Hospital Universitario Infanta Leonor
- Primary completion
- Dec 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of HCV Infected Paticipants Whom Result of the Test Was Delivered to |
101 | — |
| PRIMARY Percentage of Participants Who Were Evaluated at a HCV Clinic. |
63 | — |
| PRIMARY Percentage of Participants Who Started HCV Antiviral Therapy. |
52 | — |
| PRIMARY Percentage of Participants Who Achieved a Sustained Virological Response (SVR) |
38; 38 | — |
| SECONDARY Percentage of Participants With Active HCV in Screened Population |
122 | — |
| SECONDARY Prevalence of Other Chronic Viral Infections in the Population Screened |
35; 23; 2 | — |
Summary
Screening, diagnosis and treatment of HCV in PWID, should be part of a harm reduction strategy. Treatment of HCV infected PWID should be delivered in a multidisciplinary care setting with services to reduce the risk of reinfection and for management of the common social and psychiatric comorbidities in this population. More frequent diagnosis, new methods that prevent loss of tracking, and access to antiviral treatment are all strategies that must be implemented jointly if the prevalence of HCV infection in our setting is to be reduced.
Eligibility Criteria
Inclusion Criteria
- PWID
- >18 years of age
- Signed consent form
Exclusion Criteria
Data sourced from ClinicalTrials.gov (NCT02971488). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.